ALK and mature T-cell and NK-cell non-Hodgkin lymphoma: In conclusion, despite the varying results across studies, autologous stem cell transplantation remains widely endorsed as a consolidation approach for fit PTCL patients who do not have ALK-positive ALCL and are in CR1.